Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: LYB position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on LYB, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 0 LYB shares at 2025-12-31 per its 13F-HR filed 2026-02-05.

the latest 13F is the newest step

  1. period ended2025-12-31
    13F 0 shares
    Change vs previous 13F -238,718 shares

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-09-30
    13F 238,718 shares
    Change vs previous 13F +29,099 shares

    0.26% of the 13F portfolio, value $11,707,614.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-06-30
    13F 209,619 shares
    Change vs previous 13F +100,278 shares

    0.38% of the 13F portfolio, value $12,129,481.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-03-31
    13F 109,341 shares
    Change vs previous 13F +18,201 shares

    0.24% of the 13F portfolio, value $7,698,224.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-12-31
    13F 91,140 shares
    Change vs previous 13F -1,828 shares

    0.24% of the 13F portfolio, value $6,769,514.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2024-09-30
    13F 92,968 shares
    Change vs previous 13F not available

    0.31% of the 13F portfolio, value $8,916,274.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).